Patterson Companies, Inc. is a value-added specialty distributor serving the United States and Canadian dental supply markets and the United States, Canadian and United Kingdom animal health supply markets. The Companyâs segments include Dental, Animal Health and Corporate. Its Dental segment provides consumable products (including infection control, restorative materials, and instruments); basic and advanced technology and dental equipment, and practice optimization solutions, including practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education. Its Animal Health segment is a full-line distributor in North America and the United Kingdom of animal health products, services and technologies to both the production-animal and companion-pet markets. It offers a private label portfolio of products to veterinarians, producers, and retailers through its Aspen, First Companion and Patterson Veterinary brands.

Employees

7,600

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Market Closed - Nasdaq Other stock markets 21:00:00 16/04/2025 BST			5-day change	1st Jan Change
31.33 ^USD	+0.03%		-.--%	-

01-07	Patterson Companies, Inc. Appoints Patrik Eriksson as North American President of Patterson Dental	CI
22/04/25	Patterson Companies, Inc. Announces Chief Executive Officer Changes	CI

Capitalization	2.77B 2.36B 2.19B 2.06B 3.83B 252B 4.11B 25.27B 9.98B 120B 10.39B 10.18B 438B	P/E ratio 2023	12.8x	P/E ratio 2024	13x
Enterprise value	3.43B 2.92B 2.71B 2.55B 4.74B 312B 5.08B 31.25B 12.35B 148B 12.86B 12.59B 541B	EV / Sales 2023	0.48x	EV / Sales 2024	0.45x
Free-Float	98.79%	Yield 2023	3.84%	Yield 2024	4.04%

01-07	Patterson Companies, Inc. Appoints Patrik Eriksson as North American President of Patterson Dental	CI
22/04/25	Patterson Companies, Inc. Announces Chief Executive Officer Changes	CI
17/04/25	Patterson Companies, Inc.(NasdaqGS:PDCO) dropped from NASDAQ Composite Index	CI
17/04/25	Banks Stuck With Buyout Debt as Patterson Deals Closes	MT
16/04/25	Patterson Companies, Inc.'s Equity Buyback announced on March 12, 2024, has expired.	CI
16/04/25	Patient Square Capital, LP completed the acquisition of Patterson Companies, Inc..	CI
16/04/25	Patterson Companies, Inc.(NasdaqGS:PDCO) dropped from S&P 600 Health Care	CI
16/04/25	Patterson Companies, Inc.(NasdaqGS:PDCO) dropped from S&P 600	CI
16/04/25	Patterson Companies, Inc.(NasdaqGS:PDCO) dropped from S&P 1000	CI
16/04/25	Patterson Companies, Inc.(NasdaqGS:PDCO) dropped from S&P TMI Index	CI
16/04/25	Patterson Companies, Inc.(NasdaqGS:PDCO) dropped from S&P Global BMI Index	CI
16/04/25	Patterson Companies, Inc.(NasdaqGS:PDCO) dropped from S&P Health Care Services Select Industry Index	CI
16/04/25	Patterson Companies, Inc.(NasdaqGS:PDCO) dropped from S&P Composite 1500	CI

17/12/24	Morgan Stanley Adjusts Price Target on Patterson Companies to $31.35 From $27	MT
17/12/24	UBS Adjusts Price Target on Patterson Companies to $31.35 From $24, Keeps Neutral Rating	MT
04/12/24	Mizuho Initiates Patterson Companies at Neutral With $24 Price Target	MT
03/12/24	Leerink Partners Adjusts Patterson Companies Price Target to $28 From $30, Maintains Outperform Rating	MT
05/09/24	UBS Adjusts Patterson Companies Price Target to $24 From $27, Maintains Neutral Rating	MT

Patterson Companies, Inc. Share Price

Equities

PDCO

US7033951036

Medical Equipment, Supplies & Distribution

Valuation: Patterson Companies, Inc.

Chart: Patterson Companies, Inc.

Latest news: Patterson Companies, Inc.

Analysts' recommendations: Patterson Companies, Inc.

Press Releases: Patterson Companies, Inc.

News in other languages: Patterson Companies, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Patterson Companies, Inc.

ETFs: Patterson Companies, Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Income Statement and Estimates

01/04/25	Patterson Companies, Inc. Shareholders Approve Acquisition by Patient Square Capital	BU
26/02/25	Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results	BU
25/02/25	PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders	BU
21/01/25	Patterson Companies Announces Expiration of “Go-Shop” Period	BU
11/12/24	$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Patterson Companies, Inc. - PDCO	PR

18/07/24	Pearl et Patterson Dentaire Canada s'associent pour promouvoir l'IA dentaire dans le secteur de la dentisterie au Canada
30/08/23	USA-Les valeurs à suivre à Wall Street (actualisé)
10/08/18	Dow Jones Industrial Average : Les valeurs à suivre à Wall Street
10/08/18	USA-Les valeurs à suivre à Wall Street (actualisé)
13/02/18	POINT Marchés-Wall Street finit sur une hausse prudente avant l'inflation

1 year	30.56	31.34
3 years	19.45	34.53
5 years	19.45	37.37
10 years	12.93	50.4

Manager	Title	Age	Since
Robert Rajalingam CEO	Chief Executive Officer	-	31/03/2025
Kevin Barry DFI	Director of Finance/CFO	48	11/10/2022
Shivani Kaul CMP	Compliance Officer	-	29/02/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
PATTERSON COMPANIES, INC.	+0.03%	-.--%	+1.39%	+8.41%	2.77B
ABBOTT LABORATORIES	-0.51%	-2.54%	+6.75%	+7.37%	212B
MEDTRONIC PLC	+1.90%	+2.26%	+11.94%	+21.86%	124B
CENCORA, INC.	-1.18%	+1.38%	+44.88%	+116.18%	68.84B
BECTON, DICKINSON AND COMPANY	-1.80%	+0.93%	-14.32%	-19.87%	59.01B
HOYA CORPORATION	-0.46%	-3.97%	+17.42%	+82.35%	53.93B
MEDLINE INC.	+0.07%	+3.03%	-	-	36.72B
DEXCOM, INC.	+1.71%	+0.68%	-16.18%	-34.42%	27.12B
STERIS PLC	-3.97%	-0.72%	+23.08%	+25.78%	26.37B
SARTORIUS STEDIM BIOTECH	+0.05%	-3.87%	+2.99%	-34.04%	23.37B
Average	-0.38%	+1.87%	+8.66%	+19.29%	63.39B
Weighted average by Cap.	-0.09%	+1.08%	+10.61%	+24.30%

	2023	2024
Net sales	6.47B 5.52B 5.11B 4.81B 8.95B 589B 9.6B 58.99B 23.31B 280B 24.27B 23.77B 1,022B	6.57B 5.6B 5.19B 4.88B 9.08B 598B 9.74B 59.87B 23.65B 284B 24.63B 24.13B 1,037B
Net income	208M 177M 164M 154M 287M 18.89B 308M 1.89B 747M 8.98B 778M 762M 32.78B	186M 158M 147M 138M 257M 16.92B 276M 1.69B 670M 8.05B 697M 683M 29.36B
Net Debt	476M 405M 376M 353M 658M 43.3B 705M 4.34B 1.71B 20.59B 1.78B 1.75B 75.13B	656M 559M 518M 487M 907M 59.72B 973M 5.98B 2.36B 28.4B 2.46B 2.41B 104B